Baxter International (BAX) Price to Sales (2009 - 2026)

Baxter International (BAX) has reported Price to Sales for 18 consecutive years, with 3.72 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 32.72% year-over-year to 3.72 in Q2 2026; TTM through Jun 2026 was 0.99, a 30.46% decrease from a year earlier, with the FY2025 full-year figure at 0.87, down 37.66% from the prior year.
• Price to Sales was 3.72 for Q2 2026 at Baxter International, up from 3.21 in the prior quarter.
• Over five years, Price to Sales peaked at 10.97 in Q1 2022 and troughed at 3.21 in Q1 2026.
• A 5-year average of 7.07 and a median of 7.19 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales slumped 54.18% in 2022 and rose 4.74% in 2023, its largest moves.
• Over 5 years, Price to Sales stood at 6.87 in 2022, then increased by 4.74% to 7.19 in 2023, then fell by 24.67% to 5.42 in 2024, then rose by 2.13% to 5.53 in 2025, then tumbled by 32.72% to 3.72 in 2026.
• The last three Price to Sales figures came in at 3.72 (Q2 2026), 3.21 (Q1 2026), and 5.53 (Q2 2025), per Business Quant data.